Dr. Mkhitaryan is an oncologist in the Adults Solid Tumors Chemotherapy Department at the Yeolyan Hematology and Oncology Center, where he combines clinical expertise with active involvement in innovative cancer research. Having progressed from an on-call physician to a specialized oncology role, Dr. Mkhitaryan is dedicated to advancing patient-centered cancer care and improving treatment outcomes for patients with solid tumors. In parallel with his clinical responsibilities, he serves as a Clinical Study Coordinator at IMMONC, contributing to the coordination and implementation of advanced oncology clinical trials. He is currently involved in the clinical study “Assessment of the Safety and Efficacy of Balstilimab in Combination with Botensilimab for the Treatment of Non-Small Cell Lung Cancer” (NCT06322108), supporting the integration of innovative immunotherapy strategies into modern cancer treatment. Through his combined work in patient care and clinical research, Dr. Mkhitaryan contributes to expanding access to emerging therapies and advancing the future of oncology research.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.